Background: Myelodysplastic syndrome (MDS) is a term used to encompass a spectrum of
clonal (neoplastic) myeloid disorders The combination of obvious marrow dysplasia and …

Introduction: The myelodysplastic syndrome (MDS) is a monoclonal stem cell disease which
may cause peripheral cytopenias such as anaemia, thrombocytopenia and neutropenia …

Background: Myelodysplastic syndromes (MDS) are a heterogeneous group of
hematopoietic disorders, which can be difficult to diagnose based only on morphologic bone …

Multiparameter flow cytometry (MFC) is increasingly being used as an adjunct to the
diagnostic work-up in myelodysplastic syndromes (MDS). While many antigens have been …

Introduction: Myelodysplastic syndrome (MDS) comprises a heterogeneous group of clonal
hematopoietic stem cell diseases with variable clinical course and risk of evolution to acute …

Abstract 4846 Myelodysplastic syndrome (MDS) is heterogeneous clonal hematopoietic
stem cell disorder characterized by cytopenia (s) and dysplasia in one or more cell lineage …

The myelodysplastic syndromes (MDSs) are a group of heterogeneous hematological
disorders characterized by bilineage or trilineage dysplastic morphology, abnormal clonal …

Introduction: Myelodysplastic syndromes (MDSs) are a group of disorders characterised by
ineffective haematopoiesis, leading to dysplasia in one, two or all three cell lineages …

Diagnosis and classification of myelodysplastic syndromes (MDS) have traditionally been
based on histopathologic and clinical features consisting of cytopenias, dysplastic …

Background Confirming diagnosis of myelodysplastic syndromes (MDS) is often
challenging. Standard diagnostic methods are cytomorphology (CM) and cytogenetics …